Human Pathology, ISSN 0046-8177, 2013, Volume 44, Issue 10, pp. 1982 - 1988
Summary Mammary analogue secretory carcinoma is a recently described salivary gland neoplasm defined by ETV6-NTRK3 gene fusion. Mammary analogue secretory...
Pathology | Mammary analogue secretory carcinoma | Acinic cell carcinoma | ETV6-NTRK3 | Mammaglobin | GCDFP-15 | ENTITY | DUCT CARCINOMA | PAROTID-GLAND | PATHOLOGY | VARIANT | Translocation, Genetic | Oncogene Proteins, Fusion - metabolism | Carcinoma, Adenoid Cystic - pathology | Tissue Array Analysis | Carcinoma, Adenoid Cystic - metabolism | Humans | Carcinoma, Acinar Cell - pathology | Adenoma, Pleomorphic - metabolism | Carcinoma, Mucoepidermoid - metabolism | Breast Neoplasms - metabolism | Carcinoma, Mucoepidermoid - pathology | Cystadenocarcinoma - metabolism | Immunohistochemistry - methods | Carcinoma, Acinar Cell - metabolism | Cystadenocarcinoma - pathology | Breast Neoplasms - pathology | Mammaglobin A - metabolism | Adenoma, Pleomorphic - pathology | Salivary Gland Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Female | Carcinoma - metabolism | Carcinoma - pathology | Salivary Gland Neoplasms - pathology | Immunohistochemistry | Cytogenetics | Breast cancer | Carcinoma | Diagnosis | Cancer | Cytoplasm | Tumors | acinic cell carcinoma | mammaglobin
Pathology | Mammary analogue secretory carcinoma | Acinic cell carcinoma | ETV6-NTRK3 | Mammaglobin | GCDFP-15 | ENTITY | DUCT CARCINOMA | PAROTID-GLAND | PATHOLOGY | VARIANT | Translocation, Genetic | Oncogene Proteins, Fusion - metabolism | Carcinoma, Adenoid Cystic - pathology | Tissue Array Analysis | Carcinoma, Adenoid Cystic - metabolism | Humans | Carcinoma, Acinar Cell - pathology | Adenoma, Pleomorphic - metabolism | Carcinoma, Mucoepidermoid - metabolism | Breast Neoplasms - metabolism | Carcinoma, Mucoepidermoid - pathology | Cystadenocarcinoma - metabolism | Immunohistochemistry - methods | Carcinoma, Acinar Cell - metabolism | Cystadenocarcinoma - pathology | Breast Neoplasms - pathology | Mammaglobin A - metabolism | Adenoma, Pleomorphic - pathology | Salivary Gland Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Female | Carcinoma - metabolism | Carcinoma - pathology | Salivary Gland Neoplasms - pathology | Immunohistochemistry | Cytogenetics | Breast cancer | Carcinoma | Diagnosis | Cancer | Cytoplasm | Tumors | acinic cell carcinoma | mammaglobin
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 07/2013, Volume 37, Issue 7, pp. 1053 - 1057
Acinic cell carcinoma (ACC) is a low-grade salivary gland malignancy characterized by serous acinar differentiation. Most ACCs arise in the parotid gland, but...
S100 | Minor salivary gland carcinoma | Acinic cell carcinoma | ETV6-NTRK3 translocation | Mammaglobin | Mammary analog secretory carcinoma
S100 | Minor salivary gland carcinoma | Acinic cell carcinoma | ETV6-NTRK3 translocation | Mammaglobin | Mammary analog secretory carcinoma
Journal Article
Human Pathology, ISSN 0046-8177, 2015, Volume 46, Issue 8, pp. 1204 - 1208
Summary Adenoid cystic carcinoma (ACC) is a basaloid tumor consisting of myoepithelial and ductal cells typically arranged in a cribriform pattern. Adenoid...
Pathology | Basal cell carcinoma | MYB-NFIB | Prostate | Adenoid cystic carcinoma | Fluorescence in situ hybridization | NEOPLASMS | TUMOR | CLASSIFICATION | PATHOLOGY | HYPERPLASIA | BREAST | CHROMOSOMAL REARRANGEMENTS | GENE FUSIONS | NFIB | EXPRESSION | GLAND | Prostatic Neoplasms - pathology | Carcinoma, Adenoid Cystic - pathology | Carcinoma, Basal Cell - genetics | Genes, myb - genetics | Humans | In Situ Hybridization, Fluorescence | Male | Carcinoma, Basal Cell - pathology | Prostatic Neoplasms - genetics | Carcinoma, Adenoid Cystic - genetics | Oncogene Proteins, Fusion - genetics | Aged, 80 and over | Aged | Carcinoma | Harbors | Analysis | Cancer | Studies | Transcription factors | Classification schemes | Sunscreen | Genes | Morphology | Classification | Gangrene | Hybridization | Tumors
Pathology | Basal cell carcinoma | MYB-NFIB | Prostate | Adenoid cystic carcinoma | Fluorescence in situ hybridization | NEOPLASMS | TUMOR | CLASSIFICATION | PATHOLOGY | HYPERPLASIA | BREAST | CHROMOSOMAL REARRANGEMENTS | GENE FUSIONS | NFIB | EXPRESSION | GLAND | Prostatic Neoplasms - pathology | Carcinoma, Adenoid Cystic - pathology | Carcinoma, Basal Cell - genetics | Genes, myb - genetics | Humans | In Situ Hybridization, Fluorescence | Male | Carcinoma, Basal Cell - pathology | Prostatic Neoplasms - genetics | Carcinoma, Adenoid Cystic - genetics | Oncogene Proteins, Fusion - genetics | Aged, 80 and over | Aged | Carcinoma | Harbors | Analysis | Cancer | Studies | Transcription factors | Classification schemes | Sunscreen | Genes | Morphology | Classification | Gangrene | Hybridization | Tumors
Journal Article
The Journal of Pathology, ISSN 0022-3417, 03/2014, Volume 232, Issue 4, pp. 428 - 435
Pancreatic carcinomas with acinar differentiation, including acinar cell carcinoma, pancreatoblastoma and carcinomas with mixed differentiation, are distinct...
genetics | pancreatoblastoma | carcinoma | pancreas | acinar cell carcinoma | sequencing | METHYLATION | HUMAN BREAST | INHIBITION | ONCOLOGY | PATHWAY | MUTATIONS | PATHOLOGY | PANCREATOBLASTOMA | HETEROZYGOSITY | CELL-CARCINOMA | ALLELOTYPE | INSIGHTS | Genetic Predisposition to Disease | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Carcinoma, Acinar Cell - pathology | Gene Expression Regulation, Neoplastic | In Situ Hybridization, Fluorescence | Male | Pancreatic Neoplasms - genetics | Carcinoma, Acinar Cell - genetics | Exome | Cell Differentiation - genetics | Phenotype | Acinar Cells - pathology | Acinar Cells - chemistry | Carcinoma, Acinar Cell - surgery | DNA Mutational Analysis | Female | Biomarkers, Tumor - genetics | Chromosomes, Human | DNA, Neoplasm - analysis | Mutation | Fluorescence | Tumor proteins | Analysis | Genes | Tumors
genetics | pancreatoblastoma | carcinoma | pancreas | acinar cell carcinoma | sequencing | METHYLATION | HUMAN BREAST | INHIBITION | ONCOLOGY | PATHWAY | MUTATIONS | PATHOLOGY | PANCREATOBLASTOMA | HETEROZYGOSITY | CELL-CARCINOMA | ALLELOTYPE | INSIGHTS | Genetic Predisposition to Disease | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Pancreatic Neoplasms - surgery | Carcinoma, Acinar Cell - pathology | Gene Expression Regulation, Neoplastic | In Situ Hybridization, Fluorescence | Male | Pancreatic Neoplasms - genetics | Carcinoma, Acinar Cell - genetics | Exome | Cell Differentiation - genetics | Phenotype | Acinar Cells - pathology | Acinar Cells - chemistry | Carcinoma, Acinar Cell - surgery | DNA Mutational Analysis | Female | Biomarkers, Tumor - genetics | Chromosomes, Human | DNA, Neoplasm - analysis | Mutation | Fluorescence | Tumor proteins | Analysis | Genes | Tumors
Journal Article
The Laryngoscope, ISSN 0023-852X, 09/2015, Volume 125, Issue 9, pp. E292 - E299
Objectives Salivary gland adenoid cystic carcinoma (ACC) is rare, aggressive, and challenging to treat. Many ACCs have a t(6;9) chromosomal translocation...
MYB | survival | disease‐free survival | MYB‐NFIB fusion gene | salivary gland neoplasms | Adenoid cystic carcinoma | minor salivary glands | disease-free survival | MYB-NFIB fusion gene | SURGERY | MEDICINE, RESEARCH & EXPERIMENTAL | FUSION | SALIVARY-GLANDS | RADIATION | THERAPY | NFIB | PREDICTORS | OTORHINOLARYNGOLOGY | RECURRENCE | EXPRESSION | Salivary Gland Neoplasms - mortality | Survival Rate - trends | Carcinoma, Adenoid Cystic - pathology | Follow-Up Studies | Salivary Gland Neoplasms - genetics | Humans | Middle Aged | In Situ Hybridization, Fluorescence | Male | Young Adult | Disease-Free Survival | Carcinoma, Adenoid Cystic - mortality | Carcinoma, Adenoid Cystic - genetics | Oncogene Proteins, Fusion - genetics | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | DNA, Neoplasm - genetics | Gene Rearrangement - genetics | Neoplasm Staging | Salivary Gland Neoplasms - pathology | Development and progression | Carcinoma | Cancer
MYB | survival | disease‐free survival | MYB‐NFIB fusion gene | salivary gland neoplasms | Adenoid cystic carcinoma | minor salivary glands | disease-free survival | MYB-NFIB fusion gene | SURGERY | MEDICINE, RESEARCH & EXPERIMENTAL | FUSION | SALIVARY-GLANDS | RADIATION | THERAPY | NFIB | PREDICTORS | OTORHINOLARYNGOLOGY | RECURRENCE | EXPRESSION | Salivary Gland Neoplasms - mortality | Survival Rate - trends | Carcinoma, Adenoid Cystic - pathology | Follow-Up Studies | Salivary Gland Neoplasms - genetics | Humans | Middle Aged | In Situ Hybridization, Fluorescence | Male | Young Adult | Disease-Free Survival | Carcinoma, Adenoid Cystic - mortality | Carcinoma, Adenoid Cystic - genetics | Oncogene Proteins, Fusion - genetics | Adolescent | Aged, 80 and over | Adult | Female | Aged | Retrospective Studies | DNA, Neoplasm - genetics | Gene Rearrangement - genetics | Neoplasm Staging | Salivary Gland Neoplasms - pathology | Development and progression | Carcinoma | Cancer
Journal Article
Journal of Neuropathology and Experimental Neurology, ISSN 0022-3069, 10/2006, Volume 65, Issue 10, pp. 988 - 994
Deletions of portions of chromosomes 1p and 19q are closely associated with the oligodendroglioma histologic phenotype. In most cases, 1p and 19q are...
Brain tumor | Chromosome | Karyotype | Fluorescent in situ hybridization (FISH) | Oligodendroglioma | fluorescent in situ hybridization (FISH) | DIAGNOSIS | oligodendroglioma | chromosome | ASTROCYTOMAS | brain tumor | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | BRAIN-TUMORS | CHROMOSOME-ABNORMALITIES | karyotype | ALPHA-SATELLITE DNA | WHOLE-ARM TRANSLOCATION | NERVOUS-SYSTEM TUMORS | HUMAN GLIOMAS | COMPARATIVE GENOMIC HYBRIDIZATION | MIXED OLIGOASTROCYTOMAS | Chromosome Deletion | Translocation, Genetic | Oligodendroglioma - genetics | Humans | Brain Neoplasms - genetics | In Situ Hybridization, Fluorescence | Male | Loss of Heterozygosity | Chromosomes, Human, Pair 19 | Chromosomes, Human, Pair 1 | Chromosome Aberrations | Adult | Female
Brain tumor | Chromosome | Karyotype | Fluorescent in situ hybridization (FISH) | Oligodendroglioma | fluorescent in situ hybridization (FISH) | DIAGNOSIS | oligodendroglioma | chromosome | ASTROCYTOMAS | brain tumor | PATHOLOGY | NEUROSCIENCES | CLINICAL NEUROLOGY | BRAIN-TUMORS | CHROMOSOME-ABNORMALITIES | karyotype | ALPHA-SATELLITE DNA | WHOLE-ARM TRANSLOCATION | NERVOUS-SYSTEM TUMORS | HUMAN GLIOMAS | COMPARATIVE GENOMIC HYBRIDIZATION | MIXED OLIGOASTROCYTOMAS | Chromosome Deletion | Translocation, Genetic | Oligodendroglioma - genetics | Humans | Brain Neoplasms - genetics | In Situ Hybridization, Fluorescence | Male | Loss of Heterozygosity | Chromosomes, Human, Pair 19 | Chromosomes, Human, Pair 1 | Chromosome Aberrations | Adult | Female
Journal Article
Journal of Pathology, ISSN 0022-3417, 05/2017, Volume 242, Issue 1, pp. 16 - 23
High-grade pancreatic intraepithelial neoplasia (HG-PanIN) is the major precursor of pancreatic ductal adenocarcinoma (PDAC) and is an ideal target for early...
SMAD4 | cancerization | targeted next-generation sequencing | pancreas | Multicenter Study | HG-PanIN | pancreatic intraepithelial neoplasia | whole-exome sequencing | TP53 | Journal Article | pancreatic ductal adenocarcinoma | HG‐PanIN | whole‐exome sequencing | targeted next‐generation sequencing | PATHWAYS | DUCTAL ADENOCARCINOMA | TUMOR | PATHOLOGY | CANCER | LESIONS | INACTIVATION | ONCOLOGY | JUICE | MUTATIONS | EXPRESSION | PROGRESSION | Pancreatic Neoplasms - metabolism | Carcinoma in Situ - pathology | Humans | Pancreatic Neoplasms - pathology | Tumor Suppressor Protein p53 - metabolism | Pancreatic Neoplasms - genetics | Genes, p53 - genetics | Neoplasm Proteins - metabolism | Smad4 Protein - metabolism | Genome, Human - genetics | Carcinoma in Situ - genetics | Neoplasm Grading | Smad4 Protein - genetics | Mutation | Carcinoma in Situ - metabolism | High-Throughput Nucleotide Sequencing - methods | Neoplasm Proteins - genetics
SMAD4 | cancerization | targeted next-generation sequencing | pancreas | Multicenter Study | HG-PanIN | pancreatic intraepithelial neoplasia | whole-exome sequencing | TP53 | Journal Article | pancreatic ductal adenocarcinoma | HG‐PanIN | whole‐exome sequencing | targeted next‐generation sequencing | PATHWAYS | DUCTAL ADENOCARCINOMA | TUMOR | PATHOLOGY | CANCER | LESIONS | INACTIVATION | ONCOLOGY | JUICE | MUTATIONS | EXPRESSION | PROGRESSION | Pancreatic Neoplasms - metabolism | Carcinoma in Situ - pathology | Humans | Pancreatic Neoplasms - pathology | Tumor Suppressor Protein p53 - metabolism | Pancreatic Neoplasms - genetics | Genes, p53 - genetics | Neoplasm Proteins - metabolism | Smad4 Protein - metabolism | Genome, Human - genetics | Carcinoma in Situ - genetics | Neoplasm Grading | Smad4 Protein - genetics | Mutation | Carcinoma in Situ - metabolism | High-Throughput Nucleotide Sequencing - methods | Neoplasm Proteins - genetics
Journal Article
Journal of Pathology, ISSN 0022-3417, 2017, Volume 243, Issue 2, pp. 148 - 154
Undifferentiated carcinoma of the pancreas with osteoclast‐like giant cells (UCOGC) is currently considered a morphologically and clinically distinct variant...
undifferentiated carcinoma with osteoclast‐like giant cells | PDAC variants | whole exome sequencing | undifferentiated carcinoma with osteoclast-like giant cells | GENOMIC ANALYSES | PATHOLOGY | INTRAEPITHELIAL NEOPLASIA | CANCER | MOLECULAR ANALYSIS | GENE | ONCOLOGY | LIVER | MUTATIONS | TP53 | Immunohistochemistry | Osteoclasts - pathology | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Male | Pancreatic Neoplasms - genetics | Mutation - genetics | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - genetics | Exome - genetics | Aged, 80 and over | Carcinoma, Pancreatic Ductal - mortality | Female | Aged | Pancreatic Neoplasms - mortality | Neoplasm Proteins - genetics | Adenocarcinoma | Tumor proteins | Analysis | Pancreatic cancer | Sequences | Pancreatic carcinoma | p53 Protein | Tumor suppressor genes | Biocompatibility | Giant cells | Mutation | Pancreas | Smad4 protein | K-Ras protein
undifferentiated carcinoma with osteoclast‐like giant cells | PDAC variants | whole exome sequencing | undifferentiated carcinoma with osteoclast-like giant cells | GENOMIC ANALYSES | PATHOLOGY | INTRAEPITHELIAL NEOPLASIA | CANCER | MOLECULAR ANALYSIS | GENE | ONCOLOGY | LIVER | MUTATIONS | TP53 | Immunohistochemistry | Osteoclasts - pathology | Humans | Middle Aged | Pancreatic Neoplasms - pathology | Male | Pancreatic Neoplasms - genetics | Mutation - genetics | Carcinoma, Pancreatic Ductal - pathology | Carcinoma, Pancreatic Ductal - genetics | Exome - genetics | Aged, 80 and over | Carcinoma, Pancreatic Ductal - mortality | Female | Aged | Pancreatic Neoplasms - mortality | Neoplasm Proteins - genetics | Adenocarcinoma | Tumor proteins | Analysis | Pancreatic cancer | Sequences | Pancreatic carcinoma | p53 Protein | Tumor suppressor genes | Biocompatibility | Giant cells | Mutation | Pancreas | Smad4 protein | K-Ras protein
Journal Article
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, ISSN 0147-5185, 07/2013, Volume 37, Issue 7, pp. 1053 - 1057
Acinic cell carcinoma (ACC) is a low-grade salivary gland malignancy characterized by serous acinar differentiation. Most ACCs arise in the parotid gland, but...
SURGERY | ORIGIN | mammary analog secretory carcinoma | minor salivary gland carcinoma | mammaglobin | ETV6-NTRK3 GENE FUSION | S100 | acinic cell carcinoma | PATHOLOGY | ETV6-NTRK3 translocation | FIBROSARCOMA | MINOR SALIVARY-GLANDS | Translocation, Genetic | Humans | Middle Aged | Carcinoma, Acinar Cell - pathology | Male | Mouth Neoplasms - metabolism | Breast Neoplasms - metabolism | Submandibular Gland Neoplasms - metabolism | Young Adult | Carcinoma, Acinar Cell - metabolism | Salivary Gland Neoplasms - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Acinar Cells - metabolism | Submandibular Gland Neoplasms - pathology | S100 Proteins - metabolism | Acinar Cells - pathology | Carcinoma, Acinar Cell - surgery | Breast Neoplasms - pathology | Mammaglobin A - metabolism | Mouth Neoplasms - pathology | Aged | Salivary Gland Neoplasms - pathology | Salivary Gland Neoplasms - surgery
SURGERY | ORIGIN | mammary analog secretory carcinoma | minor salivary gland carcinoma | mammaglobin | ETV6-NTRK3 GENE FUSION | S100 | acinic cell carcinoma | PATHOLOGY | ETV6-NTRK3 translocation | FIBROSARCOMA | MINOR SALIVARY-GLANDS | Translocation, Genetic | Humans | Middle Aged | Carcinoma, Acinar Cell - pathology | Male | Mouth Neoplasms - metabolism | Breast Neoplasms - metabolism | Submandibular Gland Neoplasms - metabolism | Young Adult | Carcinoma, Acinar Cell - metabolism | Salivary Gland Neoplasms - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | Retrospective Studies | Acinar Cells - metabolism | Submandibular Gland Neoplasms - pathology | S100 Proteins - metabolism | Acinar Cells - pathology | Carcinoma, Acinar Cell - surgery | Breast Neoplasms - pathology | Mammaglobin A - metabolism | Mouth Neoplasms - pathology | Aged | Salivary Gland Neoplasms - pathology | Salivary Gland Neoplasms - surgery
Journal Article
Cancer Cytopathology, ISSN 1934-662X, 05/2013, Volume 121, Issue 5, pp. 228 - 233
BACKGROUND Mammary analogue secretory carcinoma (MASC) is a recently described salivary gland neoplasm that is defined by ETV6‐NTRK3 gene fusion. To the best...
mammary analogue secretory carcinoma | salivary glands | acinic cell carcinoma | fine‐needle aspiration | cytopathology | Mammary analogue secretory carcinoma | Cytopathology | Fine-needle aspiration | Acinic cell carcinoma | Salivary glands | FINE-NEEDLE-ASPIRATION | ONCOLOGY | PAROTID-GLAND | ETV6-NTRK3 GENE FUSION | fine-needle aspiration | PATHOLOGY | LESIONS | Adenoma, Pleomorphic - genetics | Diagnosis, Differential | Carcinoma, Mucoepidermoid - diagnosis | Salivary Gland Neoplasms - genetics | Humans | Middle Aged | Carcinoma, Acinar Cell - pathology | Adenoma, Pleomorphic - diagnosis | In Situ Hybridization, Fluorescence | Male | Carcinoma, Acinar Cell - genetics | Salivary Gland Neoplasms - diagnosis | Carcinoma, Mucoepidermoid - pathology | Young Adult | Biopsy, Fine-Needle | Carcinoma, Mucoepidermoid - genetics | Carcinoma, Acinar Cell - diagnosis | Oncogene Proteins, Fusion - genetics | Adenoma, Pleomorphic - pathology | Adult | Female | Aged | Salivary Gland Neoplasms - pathology | Research | Diagnosis | Salivary gland tumors | Pathology, Cellular | Distribution | Cancer
mammary analogue secretory carcinoma | salivary glands | acinic cell carcinoma | fine‐needle aspiration | cytopathology | Mammary analogue secretory carcinoma | Cytopathology | Fine-needle aspiration | Acinic cell carcinoma | Salivary glands | FINE-NEEDLE-ASPIRATION | ONCOLOGY | PAROTID-GLAND | ETV6-NTRK3 GENE FUSION | fine-needle aspiration | PATHOLOGY | LESIONS | Adenoma, Pleomorphic - genetics | Diagnosis, Differential | Carcinoma, Mucoepidermoid - diagnosis | Salivary Gland Neoplasms - genetics | Humans | Middle Aged | Carcinoma, Acinar Cell - pathology | Adenoma, Pleomorphic - diagnosis | In Situ Hybridization, Fluorescence | Male | Carcinoma, Acinar Cell - genetics | Salivary Gland Neoplasms - diagnosis | Carcinoma, Mucoepidermoid - pathology | Young Adult | Biopsy, Fine-Needle | Carcinoma, Mucoepidermoid - genetics | Carcinoma, Acinar Cell - diagnosis | Oncogene Proteins, Fusion - genetics | Adenoma, Pleomorphic - pathology | Adult | Female | Aged | Salivary Gland Neoplasms - pathology | Research | Diagnosis | Salivary gland tumors | Pathology, Cellular | Distribution | Cancer
Journal Article
Modern Pathology, ISSN 0893-3952, 2018, Volume 31, Issue 10, pp. 1532 - 1538
Neurofibromatosis type 1 (NF1) is a hereditary cancer predisposition syndrome characterized by frequent cutaneous and nervous system abnormalities. Patients...
NF1 INACTIVATION | GENE | PHEOCHROMOCYTOMA | LANDSCAPE | DISEASE | SOMATIC MUTATION | PANCREATITIS | PATHOLOGY | GASTROINTESTINAL STROMAL TUMORS | NERVE SHEATH TUMORS | MULTIPLE | Copy number | Genes | Neurofibromin 1 | Nervous system | Chromosome deletion | Recklinghausen's disease | Heterozygosity | Clonal deletion | Neurofibromatosis | Loss of heterozygosity | Chromosome 22 | Tumor suppressor genes | Somatostatin | Neuroendocrine tumors | Tumors | Cancer
NF1 INACTIVATION | GENE | PHEOCHROMOCYTOMA | LANDSCAPE | DISEASE | SOMATIC MUTATION | PANCREATITIS | PATHOLOGY | GASTROINTESTINAL STROMAL TUMORS | NERVE SHEATH TUMORS | MULTIPLE | Copy number | Genes | Neurofibromin 1 | Nervous system | Chromosome deletion | Recklinghausen's disease | Heterozygosity | Clonal deletion | Neurofibromatosis | Loss of heterozygosity | Chromosome 22 | Tumor suppressor genes | Somatostatin | Neuroendocrine tumors | Tumors | Cancer
Journal Article
PLoS ONE, ISSN 1932-6203, 2011, Volume 6, Issue 7, p. e22129
Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease characterized by late diagnosis and treatment resistance. Recurrent genetic alterations in...
DUCTAL ADENOCARCINOMA | EPIGENETIC INACTIVATION | ZINC-FINGER | IN-VIVO | BIOLOGY | TUMOR-SUPPRESSOR GENE | E-CADHERIN | DIFFERENTIATION | BETA-CATENIN | EXPRESSION | TRANSCRIPTION FACTORS GATA-4 | Gene Dosage - genetics | Cell Proliferation | Signal Transduction | Carcinoma in Situ - pathology | Humans | Pancreatic Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Intercellular Signaling Peptides and Proteins - genetics | Pancreatic Neoplasms - genetics | Wnt Proteins - metabolism | Carcinoma, Pancreatic Ductal - pathology | Disease Progression | GATA6 Transcription Factor - metabolism | Carcinoma, Pancreatic Ductal - genetics | Gene Knockdown Techniques | Intercellular Signaling Peptides and Proteins - metabolism | Carcinoma in Situ - genetics | Cell Line, Tumor | Wnt Proteins - antagonists & inhibitors | Chromatin | Cellular signal transduction | DNA microarrays | RNA | Pancreatic cancer | Analysis | Adenocarcinoma | Cell proliferation | Cell culture | Biotechnology | Immunoprecipitation | Media (culture) | Wnt protein | Copy number | Fluorescence | Oncology | Activation | Metastasis | Tissues | Carcinogenesis | Signal transduction | Carcinogens | Transfection | Surgery | Deoxyribonucleic acid--DNA | Binding | Medical research | Cell survival | Secretion | Medical treatment | Agar | siRNA | Tumor cell lines | Gene expression | Medicine | Pathology | Signaling | Electrophoretic mobility | Cell lines | Culture media | Laboratory animals | Dkk1 protein | Tumors | Cancer | Malalties | Pàncrees | Fetge | Càncer | Pèptids | Deoxyribonucleic acid | DNA
DUCTAL ADENOCARCINOMA | EPIGENETIC INACTIVATION | ZINC-FINGER | IN-VIVO | BIOLOGY | TUMOR-SUPPRESSOR GENE | E-CADHERIN | DIFFERENTIATION | BETA-CATENIN | EXPRESSION | TRANSCRIPTION FACTORS GATA-4 | Gene Dosage - genetics | Cell Proliferation | Signal Transduction | Carcinoma in Situ - pathology | Humans | Pancreatic Neoplasms - pathology | Gene Expression Regulation, Neoplastic | Intercellular Signaling Peptides and Proteins - genetics | Pancreatic Neoplasms - genetics | Wnt Proteins - metabolism | Carcinoma, Pancreatic Ductal - pathology | Disease Progression | GATA6 Transcription Factor - metabolism | Carcinoma, Pancreatic Ductal - genetics | Gene Knockdown Techniques | Intercellular Signaling Peptides and Proteins - metabolism | Carcinoma in Situ - genetics | Cell Line, Tumor | Wnt Proteins - antagonists & inhibitors | Chromatin | Cellular signal transduction | DNA microarrays | RNA | Pancreatic cancer | Analysis | Adenocarcinoma | Cell proliferation | Cell culture | Biotechnology | Immunoprecipitation | Media (culture) | Wnt protein | Copy number | Fluorescence | Oncology | Activation | Metastasis | Tissues | Carcinogenesis | Signal transduction | Carcinogens | Transfection | Surgery | Deoxyribonucleic acid--DNA | Binding | Medical research | Cell survival | Secretion | Medical treatment | Agar | siRNA | Tumor cell lines | Gene expression | Medicine | Pathology | Signaling | Electrophoretic mobility | Cell lines | Culture media | Laboratory animals | Dkk1 protein | Tumors | Cancer | Malalties | Pàncrees | Fetge | Càncer | Pèptids | Deoxyribonucleic acid | DNA
Journal Article
PLoS ONE, ISSN 1932-6203, 09/2016, Volume 11, Issue 9, p. e0163559
Tumor-associated inflammatory cells in classical Hodgkin lymphoma (CHL) typically out-number the neoplastic Hodgkin/Reed-Sternberg (H/RS) cells. The...
SURVIVAL | REED-STERNBERG CELLS | DENDRITIC CELLS | CCL5/RANTES | PROGNOSIS | MULTIDISCIPLINARY SCIENCES | DISEASE | REGULATORY T-CELLS | MONOCYTES | EXPRESSION | EPSTEIN-BARR-VIRUS | Relapse | Analysis | Bone marrow | Transplantation | Non-Hodgkin's lymphomas | Macrophages | Diseases | Antigens | Animal models | Transplants & implants | Bone marrow transplantation | Inflammation | Patients | Lymphoma | Studies | Pathology | Monocytes | Medical prognosis | Lymphomas | Chimerism | Archives | Hodgkin's disease | Deoxyribonucleic acid--DNA | Cancer | Tumors | Deoxyribonucleic acid | DNA
SURVIVAL | REED-STERNBERG CELLS | DENDRITIC CELLS | CCL5/RANTES | PROGNOSIS | MULTIDISCIPLINARY SCIENCES | DISEASE | REGULATORY T-CELLS | MONOCYTES | EXPRESSION | EPSTEIN-BARR-VIRUS | Relapse | Analysis | Bone marrow | Transplantation | Non-Hodgkin's lymphomas | Macrophages | Diseases | Antigens | Animal models | Transplants & implants | Bone marrow transplantation | Inflammation | Patients | Lymphoma | Studies | Pathology | Monocytes | Medical prognosis | Lymphomas | Chimerism | Archives | Hodgkin's disease | Deoxyribonucleic acid--DNA | Cancer | Tumors | Deoxyribonucleic acid | DNA
Journal Article
The American Journal of Surgical Pathology, ISSN 0147-5185, 08/2013, Volume 37, Issue 8, pp. 1150 - 1163
Xp11 translocation renal cell carcinomas (RCCs) are characterized by chromosome translocations involving the Xp11.2 breakpoint, resulting in gene fusions...
FISH | renal cell carcinoma | Xp11 translocation | TFE3 | SURGERY | TRANSLOCATION CARCINOMAS | NEOPLASMS | SOFT PART SARCOMA | PATHOLOGY | CELL CARCINOMA | FEATURES | GENE FUSIONS | CLEAR-CELL | CATHEPSIN-K | SPECTRUM | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Predictive Value of Tests | Translocation, Genetic | Kidney Neoplasms - genetics | Prognosis | Carcinoma, Renal Cell - chemistry | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Kidney Neoplasms - chemistry | Chromosomes, Human, X | Young Adult | Adult | Female | Child | Genetic Predisposition to Disease | Biomarkers, Tumor - analysis | Carcinoma, Renal Cell - pathology | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - analysis | In Situ Hybridization, Fluorescence | Pathology, Clinical - methods | Phenotype | Gene Rearrangement | Adolescent | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics | Kidney Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Referral and Consultation
FISH | renal cell carcinoma | Xp11 translocation | TFE3 | SURGERY | TRANSLOCATION CARCINOMAS | NEOPLASMS | SOFT PART SARCOMA | PATHOLOGY | CELL CARCINOMA | FEATURES | GENE FUSIONS | CLEAR-CELL | CATHEPSIN-K | SPECTRUM | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Predictive Value of Tests | Translocation, Genetic | Kidney Neoplasms - genetics | Prognosis | Carcinoma, Renal Cell - chemistry | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Kidney Neoplasms - chemistry | Chromosomes, Human, X | Young Adult | Adult | Female | Child | Genetic Predisposition to Disease | Biomarkers, Tumor - analysis | Carcinoma, Renal Cell - pathology | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - analysis | In Situ Hybridization, Fluorescence | Pathology, Clinical - methods | Phenotype | Gene Rearrangement | Adolescent | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics | Kidney Neoplasms - pathology | Aged | Biomarkers, Tumor - genetics | Referral and Consultation
Journal Article